These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32440915)

  • 1. Latest progress in molecular biology and treatment in genitourinary tumours.
    González-Del-Alba A; Arranz JÁ; Bellmunt J; Maroto JP; Fernández-Calvo O; Valderrama BP; González-Billalabeitia E; Méndez-Vidal MJ; Cassinello J; Romero-Laorden N; Climent MÁ; Puente J; Peláez I; Lázaro-Quintela M; Gallardo E; Suárez C
    Clin Transl Oncol; 2020 Dec; 22(12):2175-2195. PubMed ID: 32440915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genitourinary cancer.
    Ozols RF; Yagoda A
    Cancer Chemother Biol Response Modif; 1990; 11():602-29. PubMed ID: 2171615
    [No Abstract]   [Full Text] [Related]  

  • 3. Genitourinary cancer.
    Ozols RF; Yagoda A
    Cancer Chemother Biol Response Modif; 1987; 9():280-302. PubMed ID: 2856337
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel immunotherapies in GU malignancies.
    Drakaki A; McDermott DF
    Curr Oncol Rep; 2013 Jun; 15(3):224-31. PubMed ID: 23519772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
    Bigot F; Bonnet C; Massard C
    Bull Cancer; 2017 Apr; 104(4):370-379. PubMed ID: 28237355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targetable gene fusions and aberrations in genitourinary oncology.
    Pederzoli F; Bandini M; Marandino L; Ali SM; Madison R; Chung J; Ross JS; Necchi A
    Nat Rev Urol; 2020 Nov; 17(11):613-625. PubMed ID: 33046892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genitourinary cancer.
    Hudes GR; Ozols RF; Schilder RJ
    Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
    [No Abstract]   [Full Text] [Related]  

  • 8. Harnessing Natural Killer Cell Function for Genitourinary Cancers.
    Bhardwaj N; Farkas AM; Gul Z; Sfakianos JP
    Urol Clin North Am; 2020 Nov; 47(4):433-442. PubMed ID: 33008494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genitourinary malignancy.
    Leighton J; Clark J; Giantonio B; Ozols R; Hudes G
    Cancer Chemother Biol Response Modif; 1996; 16():524-63. PubMed ID: 8639400
    [No Abstract]   [Full Text] [Related]  

  • 10. [DGFIT: Immune and targeted therapy in urologic oncology – what can be expected?].
    Hegele A; Heinzer H; Rüttinger D; Siebels M
    Aktuelle Urol; 2012 Jul; 43(4):219-26. PubMed ID: 23035262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of RNA interference as therapeutic strategy in urologic cancer.
    Green WJ; James PA; Ratan HL
    Urology; 2011 Sep; 78(3):500-4. PubMed ID: 21741681
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy in genitourinary malignancies.
    Wattenberg MM; Fong L; Madan RA; Gulley JL
    Curr Opin Urol; 2016 Nov; 26(6):501-7. PubMed ID: 27471994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAIL-mediated signaling in prostate, bladder and renal cancer.
    Voelkel-Johnson C
    Nat Rev Urol; 2011 Jun; 8(8):417-27. PubMed ID: 21670755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination immunotherapy in genitourinary malignancies.
    Hoffman-Censits J; Wilde L
    Curr Opin Urol; 2016 Nov; 26(6):523-8. PubMed ID: 27517637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urological malignancy in Hong Kong: the trend and the practice.
    Yee CH; Ng CF
    Jpn J Clin Oncol; 2015 Dec; 45(12):1103-6. PubMed ID: 26450701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy in uropathology].
    Verkarre V; Roussel H; Granier C; Tartour E; Allory Y
    Ann Pathol; 2017 Feb; 37(1):90-100. PubMed ID: 28111042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treating scenario in genitourinary oncology: what is new? Part 2.
    Bracarda S; Montironi R; Porta C; Szczylic C; Bearz A; Cartenì G; Bellmunt J
    Future Oncol; 2013 Jun; 9(6):803-6. PubMed ID: 23718300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Towards the individualisation of prescriptions in oncology: urogenital cancers].
    Pouessel D; Culine S
    Bull Cancer; 2008 Oct; 95(10):975-8. PubMed ID: 19004728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
    Small EJ; Halabi S; Kantoff P; D'Amico A; Stadler W; Kelley WK; Mohler J; Bajorin D; Vogelzang NJ
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3596s-600s. PubMed ID: 16740791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genitourinary cancer.
    Hudes GR; Grana G; Deshields MS; Ozols RF
    Cancer Chemother Biol Response Modif; 1992; 13():508-40. PubMed ID: 1389919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.